Cover Image

Cardiac surgery anesthesia and systemic inflammatory response

Mohammad Ali Sheikhi, Ahmad Ebadi, Alireza Shahriary, Hannaneh Davoodzadeh, Hossein Rahmani*

Abstract


Cardiac surgery is associated with the development of a systemic inflammatory response. Inflammation represents the response of the body to tissue injury and in normal circumstances is a controlled humoral and cellular response that will lead to control of infection and wound healing. In some instances this response may become exaggerated, ultimately leading to additional tissue injury and the development of organ dysfunction. In this paper we discuss about relationships between cardiac surgery anesthesia and systemic inflammatory response.

Keywords


Cardiac surgery; Anesthesia; Agent; Systemic inflammatory response

Full Text:

PDF

References


Baki ED, Aldemir M, Kokulu S, Koca HB, Ela Y, Sıvacı RG, Özturk, NK, Emmiler M, Adalı F & Uzel H. 2013. Comparison of the effects of desflurane and propofol anesthesia on the inflammatory response and S100β protein during coronary artery bypass grafting. Inflammation, 36, 1327-1333.

Bone RC. 1996. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Critical care medicine, 24, 163-172.

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein R & Sibbald WJ. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest Journal, 101, 1644-1655.

Brix‐Christensen V, Tønnesen E, Sørensen I, Bilfinger T, Sanchez R & Stefano G. 1998. Effects of anaesthesia based on high versus low doses of opioids on the cytokine and acute‐phase protein responses in patients undergoing cardiac surgery. Acta anaesthesiologica scandinavica, 42, 63-70.

Butterworth J, Mackey DC & Wasnick J. 2013. Morgan and Mikhail's Clinical Anesthesiology, McGraw Hill Professional.

Davies S, Duffy J, Wickens D, Underwood S, Hill A, Alladine M, Feneck R, Dormandy T & Walesby R. 1993. Time-course of free radical activity during coronary artery operations with cardiopulmonary bypass. The Journal of thoracic and cardiovascular surgery, 105, 979-987.

El Azab S, Rosseel P, De Lange, J, Van Wijk E, Van Strik R & Scheffer G. 2002. Effect of Vima with sevoflurane versus TIVA with propofol or midazolam-sufentanil on the cytokine response during CABG surgery. European journal of anaesthesiology, 19, 276-282.

Gil-Gomez R, Blasco-Alonso J, Reyes J, Gonzalez-Correa J & De La J. 2014. Post-operative Systemic Inflammatory Response After Cardiac Surgery Using Extracorporeal.

GUGGENBERGER, H., SCHROEDER, T., VONTHEIN, R., DIETERICH, H.-J., SHERNAN, S. & ELTZSCHIG, H. 2006. Remifentanil or sufentanil for coronary surgery: comparison of postoperative respiratory impairment. European journal of anaesthesiology, 23, 832-840.

Kapoor MC & Ramachandran T. 2004. Inflammatory response to cardiac surgery and strategies to overcome it. Annals of cardiac anaesthesia, 7, 113-128.

Khabar KS, Elbarbary MA, Khouqeer F, Devol E, Al-Gain S & Al-Halees Z. 1997. Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clinical immunology and immunopathology, 85, 97-103.

Kilger E., Heyn J, Beiras-Fernandez A, Luchting B & Weis F. 2011. Stress doses of hydrocortisone reduce systemic inflammatory response in patients undergoing cardiac surgery without cardiopulmonary bypass. Minerva anestesiologica, 77, 268-274.

Maccallum NS, Finney SJ, Gordon SE, Quinlan GJ & Evans TW. 2014. Modified criteria for the systemic inflammatory response syndrome improves their utility following cardiac surgery. CHEST Journal, 145, 1197-1203.

Ozawa T, Yoshihara K, Koyama N, Watanabe Y, Shiono N & Takanashi Y. 2000. Clinical efficacy of heparin-bonded bypass circuits related to cytokine responses in children. The Annals of thoracic surgery, 69, 584-590.

Prieto MA, Guash S, Mendez JC, Munoz C, Planas A & Reyes G. 2013. Does use of cell saver decrease the inflammatory response in cardiac surgery? Asian Cardiovascular and Thoracic Annals, 21, 37-42.

Quartin AA, Schein RM, Kett DH & Peduzzi PN 1997. Magnitude and duration of the effect of sepsis on survival. Jama, 277, 1058-1063.

Riddington DW, Venkatesh B, Boivin CM, Bonser RS, Elliott TS, Marshall T, Mountford PJ & Bion JF. 1996. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. Jama, 275, 1007-1012.

Schilling T, Kozian A, Senturk M, Huth C, Reinhold A, Hedenstierna G & Hachenberg T. 2011. Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients. Anesthesiology, 115, 65-74.

Shahian DM, Jacobs JP, Edwards FH, Brennan JM, Dokholyan RS, Prager RL, Wright CD, Peterson ED, Mcdonald DE & Grover FL. 2013. The society of thoracic surgeons national database. Heart, 99, 1494-1501.

Szekely A, Heindl B, Zahler S, Conzen PF & Becker BF. 2000. Nonuniform behavior of intravenous anesthetics on postischemic adhesion of neutrophils in the guinea pig heart. Anesthesia & Analgesia, 90, 1293-1300.

Warltier DC, Laffey JG, Boylan JF & Cheng DC. 2002. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology, 97, 215-252.

Welters I, Feurer MK, Preiss V, Muller M, Scholz S, Kwapisz M, Mogk M & Neuhäuser C. 2011. Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. British journal of anaesthesia, 106, 172-179.




DOI: http://dx.doi.org/10.21746/ijbio.2015.02.005

Refbacks

  • There are currently no refbacks.




Copyright (c) 2015 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.